BIOMAT Database Logo BIOMAT Database Logo

Editorial: Advances in cheminformatics: drug discovery, computational toxicology and nanomaterials (part I). 2015

Georgia Melagraki, and Antreas Afantitis
NovaMechanics Ltd, Nicosia, Cyprus. melagraki@novamechanics.com.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D049329 Nanostructures Materials which have structured components with at least one dimension in the range of 1 to 100 nanometers. These include NANOCOMPOSITES; NANOPARTICLES; NANOTUBES; and NANOWIRES. Nanomaterials,Nanostructured Materials,Material, Nanostructured,Materials, Nanostructured,Nanomaterial,Nanostructure,Nanostructured Material
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D057166 High-Throughput Screening Assays Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays. High-Throughput Screening,High-Throughput Biological Assays,High-Throughput Chemical Assays,High-Throughput Screening Methods,Assay, High-Throughput Biological,Assay, High-Throughput Chemical,Assay, High-Throughput Screening,Biological Assay, High-Throughput,Chemical Assay, High-Throughput,High Throughput Biological Assays,High Throughput Chemical Assays,High Throughput Screening,High Throughput Screening Assays,High Throughput Screening Methods,High-Throughput Biological Assay,High-Throughput Chemical Assay,High-Throughput Screening Assay,High-Throughput Screening Method,High-Throughput Screenings,Screening Assay, High-Throughput,Screening Method, High-Throughput,Screening, High-Throughput
D019295 Computational Biology A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories for solving biological problems including manipulation of models and datasets. Bioinformatics,Molecular Biology, Computational,Bio-Informatics,Biology, Computational,Computational Molecular Biology,Bio Informatics,Bio-Informatic,Bioinformatic,Biologies, Computational Molecular,Biology, Computational Molecular,Computational Molecular Biologies,Molecular Biologies, Computational
D064420 Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. Drug-Related Side Effects and Adverse Reaction,Adverse Drug Event,Adverse Drug Reaction,Drug Side Effects,Drug Toxicity,Side Effects of Drugs,Toxicity, Drug,Adverse Drug Events,Adverse Drug Reactions,Drug Event, Adverse,Drug Events, Adverse,Drug Reaction, Adverse,Drug Reactions, Adverse,Drug Related Side Effects and Adverse Reaction,Drug Related Side Effects and Adverse Reactions,Drug Side Effect,Drug Toxicities,Effects, Drug Side,Reactions, Adverse Drug,Side Effect, Drug,Side Effects, Drug,Toxicities, Drug

Related Publications

Georgia Melagraki, and Antreas Afantitis
Current Advances in Computational Approaches for Drug Discovery- Part I.
January 2018, Current topics in medicinal chemistry,
Georgia Melagraki, and Antreas Afantitis
EDITORIAL: Advances in Computational Structure Based Drug Discovery.
August 2013, Current pharmaceutical design,
Georgia Melagraki, and Antreas Afantitis
Editorial: advances in computational structure based drug discovery.
January 2014, Current pharmaceutical design,
Georgia Melagraki, and Antreas Afantitis
Guest Editorial: Advances in Computational Toxicology.
January 2013, Molecular informatics,
Georgia Melagraki, and Antreas Afantitis
Computational Toxicology and Drug Discovery.
January 2018, Methods in molecular biology (Clifton, N.J.),
Georgia Melagraki, and Antreas Afantitis
Editorial: Multi-target Drug Discovery - Part I.
January 2017, Current topics in medicinal chemistry,
Georgia Melagraki, and Antreas Afantitis
Current Advances in Computational Approaches for Drug Discovery- Part II.
January 2018, Current topics in medicinal chemistry,
Georgia Melagraki, and Antreas Afantitis
Recent Advances in Drug Discovery Toxicology.
December 2023, International journal of toxicology,
Georgia Melagraki, and Antreas Afantitis
Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.
February 2011, Trends in microbiology,
Georgia Melagraki, and Antreas Afantitis
Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases.
January 2021, Frontiers in chemistry,
Copied contents to your clipboard!